Role of antibiotic resistance in urinary tract infection management: a cost-effectiveness analysis
- 1 November 2021
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 225 (5) , 550.e1-550.e10
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trialBMJ, 2017
- Cost-effectiveness of antibiotic treatment of uncomplicated urinary tract infection in women: a comparison of four antibioticsBJGP Open, 2017
- The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011Open Forum Infectious Diseases, 2017
- The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysisBMC Infectious Diseases, 2016
- Urinary Tract Infection SyndromesInfectious Disease Clinics of North America, 2014
- Systematic review of the impact of urinary tract infections on health‐related quality of lifeBJU International, 2012
- Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trialBMJ, 2010
- Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW projectScandinavian Journal of Primary Health Care, 2007
- Acute Uncomplicated Urinary Tract Infection in WomenNew England Journal of Medicine, 2003
- Epidemiology of urinary tract infections: incidence, morbidity, and economic costsThe American Journal of Medicine, 2002